17-44910629-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 6P and 1B. PM2PM5PP5_ModerateBP4
The NM_002055.5(GFAP):c.1157A>G(p.Asn386Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000658 in 152,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N386H) has been classified as Uncertain significance.
Frequency
Consequence
NM_002055.5 missense
Scores
Clinical Significance
Conservation
Publications
- Alexander diseaseInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- Alexander disease type IIInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002055.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GFAP | NM_002055.5 | MANE Select | c.1157A>G | p.Asn386Ser | missense | Exon 7 of 9 | NP_002046.1 | ||
| GFAP | NM_001363846.2 | c.1157A>G | p.Asn386Ser | missense | Exon 7 of 10 | NP_001350775.1 | |||
| GFAP | NM_001242376.3 | c.1157A>G | p.Asn386Ser | missense | Exon 7 of 7 | NP_001229305.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GFAP | ENST00000588735.3 | TSL:1 MANE Select | c.1157A>G | p.Asn386Ser | missense | Exon 7 of 9 | ENSP00000466598.2 | ||
| GFAP | ENST00000585543.6 | TSL:1 | n.310A>G | non_coding_transcript_exon | Exon 2 of 4 | ||||
| GFAP | ENST00000591327.2 | TSL:1 | n.2311A>G | non_coding_transcript_exon | Exon 5 of 5 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152002Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome Cov.: 34
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152002Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74218 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 386 of the GFAP protein (p.Asn386Ser). This variant is present in population databases (no rsID available, gnomAD 0.007%). This missense change has been observed in individuals with clinical features of Alexander disease (PMID: 25982497, 27814755, 28448978, 34046764). ClinVar contains an entry for this variant (Variation ID: 2138057). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt GFAP protein function with a negative predictive value of 95%. This variant disrupts the p.Asn386 amino acid residue in GFAP. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16996408, 21756903). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at